Biaffin

Newsletter

kinases protein kinase inhibitors signaling activators kinase substrates antibodies bioluminescence assays
Recombinant Human TNFSF11 / RANKL / CD254 Protein, His Tag, 50 µg  

Recombinant Human TNFSF11 / RANKL / CD254 Protein, His Tag, 50 µg

Recombinant Human TNFSF11 / RANKL / CD254 Protein, AA Gly 64 - Asp 245, expressed from human 293 cells (HEK293), His Tag, active trimer (MALS verified)

Synonym: Recombinant, human, protein, RANKL, CD254, TRANCE, OPGL, ODF

More details

RAL-H5240-50

Availability: within 7 days

455,00 €

Background
Receptor activator of nuclear factor kappa-B ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and osteoclast differentiation factor (ODF), is known as a type II membrane protein and is a member of the tumor necrosis factor (TNF) superfamily. RANKL, through its ability to stimulate osteoclast formation and activity, is a critical mediator of bone resorption and overall bone density. Some findings also suggestion some cancer cells, particularly prostate cancer cells, can activate an increase in bone remodeling and ultimately increase overall bone production.[17] This increase in bone remodeling and bone production increases the overall growth of bone metastasizes. The overall control of bone remodeling is regulated by the binding of RANKL with its receptor or its decoy receptor, respectively, RANK and OPG.

Source
Recombinant Human TNFSF11, His Tag (active trimer) (RAL-H5240) is expressed from human 293 cells (HEK293). It contains AA Gly 64 - Asp 245 (Accession # AAC51762.1).
Predicted N-terminus: His

Molecular Characterization
This protein carries a polyhistidine tag at the N-terminus.
The protein has a calculated MW of 22.4 kDa. The protein migrates as 27-35 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Endotoxin
Less than 1.0 EU per μg by the LAL method.

Purity
>90% as determined by SDS-PAGE.

Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

Reconstitution

Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.

Bioactivity
Please refer to product data sheet.

Clinical and Translational Updates

(1) "Osteoprotective effect by interleukin-4 (IL-4) on lipoprotein-induced periodontitis"
Lima Teixeira, Henning, Cintra Magalhães et al
Cytokine (2023) 172, 156399
(2) "Molecular Subtype Classification of Postmenopausal Osteoporosis and Immune Infiltration Microenvironment Based on Bioinformatics Analysis of Osteoclast-Regulatory Genes"
Gong, Hao, Zhang et al
Biomedicines (2023) 11 (10)
(3) "Identification of hub genes associated with somatic cell score in dairy cow"
Ghiasi, Khaldari, Taherkhani
Trop Anim Health Prod (2023) 55 (5), 349
Showing 1-3 of 4150 papers.